The second installment of PBS NewsHour’s series on the antibiotics crisis delves into why the pharmaceutical industry has little incentive to develop new ones. In brief, the wise approach to new antibiotics is to develop them but hold them in … Continue reading
The medical system in encountering more and more drug-resistant disease pathogens, so-called “superbugs,” and we’re not developing new antibiotics anywhere near fast enough to fight them. One major reason is the massive overuse of antibiotics, which are too often prescribed … Continue reading